- PackSize
- 50ug/100ug
- Target
- Envelope glycoprotein
- Reactivity
- Zaire ebolavirus
- Applications
- ELISA, Bioactivity: FACS, Functional assay, Research in vivo
- Host Species
- Chimeric
- Isotype
- IgG1, kappa
- Conjugate/Modification
- --
- Recommended Dilution Ratio
- --
- Composition
- 0.01M PBS, pH 7.4.
- Purification Process
- Protein A/G purified from cell culture supernatant.
- Purity
- >95% purity as determined by SDS-PAGE.
- storageCondition
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
- Clonality
- Monoclonal
- Clone Number
- --
- Immunogen
- Mammalian Cells
- Alias
- Envelope glycoprotein, GP1, 2, GP, Shed GP, GP1, 2-delta, GP1, GP2, GP
- Species
- --
- Gene ID-1
- Q05320
- Uniprot
- --
- Background
- Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection.<br>
- Tissue Expression
- --
- Signaling_pathway
- --
- Research Areas
- --